Page 9 - Clinical Modification News Today

The International Classification of Diseases Clinical Modification, revision 10, Clinical Modification system (ICD-10-CM) will now include PHTS.A unique code for PHTS (Q85.81) will be incorporated into the revision to be published on October 1, 2022.The code will improve patient care and facilitate future clinical,...

Profiling Disease and Economic Burden in CRSwNP Using Machine Learning

The proportion of patients with post-traumatic stress disorder (PTSD) that remain undiagnosed may be substantial. Without an accurate diagnosis, these patients may lack PTSD-targeted treatments and experience adverse health outcomes. This study used a machine learning approach to identify and describe civilian patients likely to have undiagnosed PTSD in the US commercial population. The IBM® MarketScan® Commercial Subset (10/01/2015–12/31/2018) was used. A random forest machine l...

Researchers compared in-hospital mortality across COVID-19 pandemic periods.

Researchers assessed the prevalence of neurologic complications in children hospitalized with COVID-19.

This cohort study uses data from the US Food and Drug Administration Sentinel System to measure the 90-day risk of arterial thromboembolism and venous thromboem

Dr. James V. Anderson highlights the dental code changes that are set to go into effect on January 1, 2023.

Background Biliary atresia (BA) is a rare but severe cause of obliterative cholangiopathy in neonates. Its incidence differs worldwide varying from 5/100,000 to 32/100,000 live births. The highest incidence is seen in Asia and the Pacific region. Diagnosing this disease is difficult in its early stages; thus, screening is necessary to avoid serious complications that can be minimized with early intervention during the first few months of life. Currently, although there are no medical treatments ...

/PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals, ("Salix"), one of the...

In a new study, researchers assessed the incidence of post-COVID-19 symptoms and conditions among children and adolescents.